The human p53 gene, a putative tumor suppressor gene, has a polymorphism in amino acid residue 72. We recently developed a method of detecting codon 72 polymorphism in this gene by digestion of polymerase chain reaction-amplified DNA using an allele-specific restriction endonuclease. This polymorphi
Prognostic significance of the loss of heterozygosity of nm23-h1 and p53 genes in human colorectal carcinomas
โ Scribed by Elias Campo; Rosa Miquel; Pedro Jares; Francesc Bosch; Manel Juan; Alvaro Leone; Jordi Vives; Antonio Cardesa; Jordi Yague
- Publisher
- John Wiley and Sons
- Year
- 1994
- Tongue
- English
- Weight
- 788 KB
- Volume
- 73
- Category
- Article
- ISSN
- 0008-543X
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
BACKGROUND. The clinical course of laryngeal squamous cell carcinoma (LSCC) varies considerably among patients. New biologic markers are needed to facilitate the stratification of individual patients within the conventional clinicopathologic stages of LSCC. METHODS. Eighty-three LSCCs from an equal
## Background and Objective: The purpose of this retrospective study was to test whether the expression of p53, nm23, and bcl-2 in T 3-4 N 1 M 0 oesophageal carcinoma is associated with patient survival. Methods: Immunohistochemical localisation of p53, nm23, and bcl-2 was performed on formalin-fi
p2lCipl was first isolated as one of the cyclin-dependent kinase (Cdk) interacting proteins induced by wild-type p53 gene product, and it appears to play an essential regulatory role in the control of cell proliferation as a potent, tight-binding inhibitor of cyclin-Cdk complex that blocks the G,/S